Pharmaco - Articles

In this article, we outline ten of the top pharmaceutical companies in the world, including Roche, Johnson and Johnson and Pfizer.
In this article, we outline ten of the top pharmaceutical companies in the world… Roche Founded in Switzerland in 1896, Roche has been a pioneer in healthcare for almost 125 years. The company discovers innovative pharmaceuticals and diagnostics to help millions of patients globally, and is the global leader in cancer treatments; with medicines treating breast, skin, colon, lung, and numerous other cancers. Roche also offers a diverse portfolio of biopharmaceuticals, with 17 currently on the market. The company has over 90,000 employees working across more than 100 countries, and group sales at the end of 2020 reached over $63 billion, with Roche’s pharmaceutica…

Australia is home to a multi-billion-dollar pharmaceutical market that has been growing continuously over the past decade especially. Here are ten of the top pharmaceutical companies in the country as of 2021.
Australia is home to a multi-billion-dollar pharmaceutical market that has been growing continuously over the past decade especially. Here are ten of the top pharmaceutical companies in the country as of 2021… Pfizer Pfizer has manufacturing sites in Sydney, Melbourne, Perth and Adelaide, and its products are used in hospitals and pharmacies across the country. Pfizer Australia offers a portfolio containing some of the world’s best-known prescription medicines, vaccines, and OTC products. Roche Roche is dedicated to improving the health and wellbeing of people in Australia and has had…

Warehouse management software (WMS) can be used to improve efficiency in almost any kind of supply chain, and pharmaceutical logistics is no exception. In this article, Edward Napier-Fenning, New Business Development Manager at Balloon One, shares four key benefits of optimising the supply chain using the latest WMS technology.
The pharmaceutical supply chain presents unique logistical challenges. For one thing, many products in this sector are subject to extensive compliance regulations that dictate how a particular product must be transported, stored, and distributed. Stringent time constraints and use-before dates can also apply, and in many cases, additional care must be taken to ensure that pharmaceutical supplies are not compromised or contaminated. All of this makes the supply chain…

15 pharmaceutical events taking place in July 2021, listed on PharmiWeb.com.
15 pharmaceutical events taking place in July 2021: PM Society Training: The ABPI Code 2021: A guide for the busy (July 1st) Are you one of those people who know there have been big changes to the Code of Practice this year but you aren’t quite sure what they are and you’ve no time to find out? This short, sharp, interactive summary of the 2021 code is for you. PM Society Training: Managing Pressure & Building Resilience (July 1st-2nd) These two sessions are rooted in the science of how the body and brain react to pressure and stress and offer a practical and non-fluffy guide to maintaining and building your resilience. The need for support in this area has increased given how working from home is affecting peo…

Helicobacter pylori (Hp) is closely related to the occurrence and development of gastric cancer, peptic ulcer, Hp-related dyspepsia and other diseases. Studies have found that Hp can cause gastric microbial disorders, change the microbial diversity and community structure in the stomach, and cause precancerous lesions. The public health community has made great efforts to eradicate Hp for a long time, but the current Hp infection rate in the entire population is still over 50%. In recent years, probiotics have attracted attention due to their relative safety, and microecological therapy has brought new ideas for the treatment of Hp.
Helicobacter pylori (Hp) is closely related to the occurrence and development of gastric cancer, peptic ulcer, Hp-related dyspepsia and other diseases. Studies…

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, is pleased to announce the acquisition of the assay development and biological screening provider, Aurelia Bioscience.
The sector-leading expertise and technology development within Aurelia Bioscience will enable and enhance Charnwood’s provision of a world-class integrated drug discovery and development service platform as it continues to build upon its strong foundation in medicinal chemistry, scale-up and process research & development. Aurelia Bioscience is a leading preclinical CRO specialising in bioassay development, pharmacological profiling and compound screening, working in the early stages of the drug discovery pipeline including target identifica…

Germany is home to one of the largest pharma markets in the world. Here are ten of the top pharmaceutical companies in the country: Boehringer Ingelheim - A global, research-based pharmaceutical company that works towards improving both human and animal health, specifically on diseases which currently have no successful treatment option. Boehringer Ingelheim contributes around 21% to the GDP contribution of the entire pharma industry in Germany...
Germany is home to one of the largest pharma markets in the world. Here are ten of the top pharmaceutical companies in the country: Boehringer Ingelheim A global, research-based pharmaceutical company that works towards improving both human and animal health, specifically on diseases which currently have no successful treatment option. Boehringer…

The pharmaceuticals sector is facing a raft of difficult challenges today. In broad terms, pharmaceuticals manufacturing is a complex process. Patented products are licensed for a finite amount of time before they become generic, equating to a constant sense of ‘the race is on’ to be able to meet demand. Manufacturers are focused on reducing supply chain disruption, increasing batch production capacity, and reducing batch losses.
The pharmaceuticals sector is facing a raft of difficult challenges today. In broad terms, pharmaceuticals manufacturing is a complex process. Patented products are licensed for a finite amount of time before they become generic, equating to a constant sense of ‘the race is on’ to be able to meet demand. Manufacturers are focused on reducing supply chain disruption…

How is the COVID-19 crisis influencing pharma supply chains for the future? Is the global pharma supply chain under sustained threat? And what about Asia and its dominance in the supply chain? These are all valid questions considering recent and current events.
How is the COVID-19 crisis influencing pharma supply chains for the future? Is the global pharma supply chain under sustained threat? And what about Asia and its dominance in the supply chain? These are all valid questions considering recent and current events. It is generally agreed that COVID-19 marks a point in the understanding of medicine supply risks, but will it fuel efforts to establish local supplies of chemicals and APIs as a “matter of national security”? In the last 12 months, Pharma companies have become acutely aware of…

LABWorld China 2021, organized by Informa Markets and China Chamber of Commerce for Import and Export of Medicine and Health Products and co-organized by Sinoexpo Informa Markets, will take place during 16-18 December 2021 in SNIEC Shanghai China.
Biosecurity Law has been officially implemented since 15 April 2021. Great attention has been attached to biosecurity work and a lot has been carried out in terms of national biosecurity strategy, policy and legislation. Many related tasks have been added into the provincial government reports and listed as the main objectives of China's 14th five-year plan, including but not limited to: Strengthen the biosecurity management of pathogenic microorganism laboratory, establish national key laboratories, build provincial laboratories wi…

With vaccine breakthroughs buoying the mood at the beginning of 2021, the ongoing momentum of the rollout has been cause for ongoing optimism across the UK. UK diagnostics is in a particularly promising position, with continued Covid testing complemented by a shift in emphasis towards the longer-term future.
With vaccine breakthroughs buoying the mood at the beginning of 2021, the ongoing momentum of the rollout has been cause for ongoing optimism across the UK. UK diagnostics is in a particularly promising position, with continued Covid testing complemented by a shift in emphasis towards the longer-term future. This future, as it stands, is bright. Teething problems in the UK’s Covid testing strategy may have undermined faith in an otherwise healthy sector, but this learning curve will yie…

PharmaSources.com, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event E-Trade Season together with CPhI and P-MEC China from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. This includes months of informative content and targeted matchmaking service - delivering over 8 themed webinar series and showcasing high-quality pharma suppliers from different pharmaceutical sectors. The webinars will cover topics of global pharma trends, pharma APIs supply chain, drug manufacturing and R&D, biopharmaceuticals technologies and dynamics, quality management, production technology and machinery, pharma packaging & delivery, and vitamins markets.
PharmaSources.com, an international B2B trade portal…

The Brexit transition period ended in 2020, and from 01 January 2021 the import of medicinal products to Great Britain from the EU required pharmaceutical suppliers to employ the services of a Responsible Person for Import or RPi. Prior to January 2021, it was possible for WDA holders in the EU to supply hospitals and Pharmacies in GB directly from their European distribution hubs.
The Brexit transition period ended in 2020, and from 01 January 2021 the import of medicinal products to Great Britain from the EU required pharmaceutical suppliers to employ the services of a Responsible Person for Import or RPi. Prior to January 2021, it was possible for WDA holders in the EU to supply hospitals and Pharmacies in GB directly from their European distribution hubs. This situation has now substant…

Wading through insurance industry bureaucracy is one of the most common problems faced by mental health professionals. This makes it difficult for them to collect payments on time and the impact on the collection rate eventually affects their bottom line.
Wading through insurance industry bureaucracy is one of the most common problems faced by mental health professionals. This makes it difficult for them to collect payments on time and the impact on the collection rate eventually affects their bottom line. Since Medical Billing for mental health is different compared to billing for other specialties, the process can get too overwhelming for billers who aren’t well-trained. This calls for a strong need to hire experienced professionals who are trained in handling insurance issues and can g…

Covid-19 has severely impacted the pharmaceutical industry and the supply challenges it has caused looks set to persist for the foreseeable future. Pharmaceutical companies have already experienced drug shortages, cost increases, and delivery performance degradation. In addition to this, mandates by regulatory bodies requiring jurisdictional control and in some cases the adoption of technology that does not support end-to-end supply chain collaboration has contributed to testing times.
Covid-19 has severely impacted the pharmaceutical industry and the supply challenges it has caused looks set to persist for the foreseeable future. Pharmaceutical companies have already experienced drug shortages, cost increases, and delivery performance degradation. In addition to this, mandates by regulator…

This whitepaper summarises the key elements of MHRA’s guidance document on medical devices, regarding registration, assessment procedures, labeling, post-market surveillance and vigilance that will apply for devices placed on the market in Great Britain (England, Wales and Scotland) and Northern Ireland. This document provides a list of actions that manufacturers of medical devices should take in order to continue the placement of their products on the EU and UK markets.
From January 1, 2021, the transition period after Brexit ended, and the Medicines and Healthcare products Regulatory Agency (MHRA) took on the role as the UK’s standalone medicines and medical devices regulator. On 1 September 2020, the MHRA published a set of guidance on what the rules will be from 1 January 2021. The guid…

Pharmacovigilance has developed inconceivably overall of late, and its significance when in doubt and in a general sense in the clinical thought industry has been seen. To frustrate or chop down quiet dangers, Pharmacovigilance is crucial.
Pharmacovigilance is a wide term to depict drug success. It portrays the course of action, flourishing, assessment, assumption, and checking of the malignant impacts of solutions and meds. It is a cycle driven and reliable area inside the prescription business. It is the security assessment of showed drugs separated under pragmatic or interminable states of clinical use in enormous associations. Pharmacovigilance intends to perceive dim security issues as right on time as could be viewed as average. It also plans to perceive an improvement in the rehash o…

Like never before, the superheroes in the medical profession have been applauded and profiled. In the UK, we have taken great pride in the development of treatments and vaccines, which have highlighted how the UK continues to be a great home for innovation across the life sciences spectrum. So, how does that impact the world of financial services? The short answer lies in the investment opportunities.
The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and all aspects of the healthcare system have been under the microscope. Not only the direct response to the global pandemic, with vaccinations and treatments, but also the importance of mental health, the care home profe…

The importance of R programming in clinical trials is getting upturned day by day. R can be an ideal platform for measurable investigation and data perception. To biostatisticians and programmers in the pharmaceutical and biotech industry, it offers a wide and rapidly growing range of user-created packages containing capacities that can proficiently control complex data sets and create tables, figures, and postings.
These days, an immense measure of information is gathered during any clinical trial and it is basic for pharmaceutical sponsors to comprehend this information in extraordinary detail to settle on precise choices. Analysts and programmers invest a lot of energy examining data and creating reports for clinical trials, both for conclusive trial reports and break data monitoring adv…

Innovation continues to aid pharmaceutical manufacturers to secure supply chains and protect against counterfeit medicines in the post Brexit landscape, says Dr Paul Dunn, chair of the global trade body International Hologram Manufacturers Association (IHMA).
Innovation continues to aid pharmaceutical manufacturers to secure supply chains and protect against counterfeit medicines in the post Brexit landscape, says Dr Paul Dunn, chair of the global trade body International Hologram Manufacturers Association (IHMA). Trade in counterfeit medicines is one of the largest fraud markets in the world, worth in excess of $200bn per year. It spans organised large-scale trafficking of fake drugs by criminal gangs to small traffickers pursuing illicit sales at a local level. The Covid 19 crisis is…